TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT07429942 updates: 1. start date: 2026-04-07 → 2026-06-30 2. completion date: 2026-05-01 → 2026-07-06 3. primary completion date: 2026-05-01 → 2026-07-06 4. enrollment: not set → 94 participants
Clinical trial NCT07429942 updates: 1. start date: 2026-04-07 → 2026-06-30 2. completion date: 2026-05-01 → 2026-07-06 3. primary completion date: 2026-05-01 → 2026-07-06 4. enrollment: not set → 94 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical